Cited In for PMID: 22735872

Year	Number of Results
2012	1
2014	1
2015	4
2017	2
2018	1
2019	1
2020	1
2021	1
2022	1
2024	0

1

[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].

Jeong MH, Chung JW, Lee SJ, Ha M, Jeong SH, Na S, Na BS, Park SK, Kim YJ, Kwon KA, Ko KI, Jo Y, Hahm KB, Jung HY. Jeong MH, et al. Korean J Gastroenterol. 2012 Jun 25;59(6):401-6. doi: 10.4166/kjg.2012.59.6.401. Korean J Gastroenterol. 2012. PMID: 22735872 Free article. Korean.

2

Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.

Inokuchi K, Mori H, Matsuzaki J, Hirata K, Harada Y, Saito Y, Suzuki H, Kanai T, Masaoka T. Inokuchi K, et al. Helicobacter. 2022 Aug;27(4):e12900. doi: 10.1111/hel.12900. Epub 2022 May 29. Helicobacter. 2022. PMID: 35644041 Free PMC article.

3

Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.

Singh SP, Ahuja V, Ghoshal UC, Makharia G, Dutta U, Zargar SA, Venkataraman J, Dutta AK, Mukhopadhyay AK, Singh A, Thapa BR, Vaiphei K, Sathiyasekaran M, Sahu MK, Rout N, Abraham P, Dalai PC, Rathi P, Sinha SK, Bhatia S, Patra S, Ghoshal U, Poddar U, Mouli VP, Kate V. Singh SP, et al. Indian J Gastroenterol. 2021 Aug;40(4):420-444. doi: 10.1007/s12664-021-01186-4. Epub 2021 Jul 5. Indian J Gastroenterol. 2021. PMID: 34219211

4

Rifabutin for the Treatment of Helicobacter Pylori Infection: A Review.

Gisbert JP. Gisbert JP. Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015. Pathogens. 2020. PMID: 33379336 Free PMC article. Review.

5

Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea.

Choi YI, Jeong SH, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, So S, Lee JH, Jeong JY, Lee SM. Choi YI, et al. Can J Infect Dis Med Microbiol. 2019 Jul 10;2019:9351801. doi: 10.1155/2019/9351801. eCollection 2019. Can J Infect Dis Med Microbiol. 2019. PMID: 31360270 Free PMC article.

6

Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis.

An Y, Wang Y, Wu S, Wang YH, Qian X, Li Z, Fu YJ, Xie Y. An Y, et al. World J Gastroenterol. 2018 Aug 7;24(29):3302-3312. doi: 10.3748/wjg.v24.i29.3302. World J Gastroenterol. 2018. PMID: 30090010 Free PMC article.

7

In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains.

Chung JW, Kim SY, Park HJ, Chung CS, Lee HW, Lee SM, Kim I, Pak JH, Lee GH, Jeong JY. Chung JW, et al. Gut Liver. 2017 Sep 15;11(5):648-654. doi: 10.5009/gnl16503. Gut Liver. 2017. PMID: 28750485 Free PMC article.

8

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.

Lim JH, Kim SG, Song JH, Hwang JJ, Lee DH, Han JP, Hong SJ, Kim JH, Jeon SW, Kim GH, Shim KN, Shin WG, Kim TH, Kim SM, Chung IK, Kim HS, Kim HU, Lee J, Kim JG. Lim JH, et al. Gut Liver. 2017 Mar 15;11(2):226-231. doi: 10.5009/gnl16099. Gut Liver. 2017. PMID: 27609487 Free PMC article.

9

Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis.

Lee SW, Kim HJ, Kim JG. Lee SW, et al. J Korean Med Sci. 2015 Aug;30(8):1001-9. doi: 10.3346/jkms.2015.30.8.1001. Epub 2015 Jul 15. J Korean Med Sci. 2015. PMID: 26240475 Free PMC article. Review.

10

Current Helicobacter pylori treatment in 2014.

Ermis F, Senocak Tasci E. Ermis F, et al. World J Methodol. 2015 Jun 26;5(2):101-7. doi: 10.5662/wjm.v5.i2.101. eCollection 2015 Jun 26. World J Methodol. 2015. PMID: 26140276 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year